MARKET

GNIIF

GNIIF

Gni Group
OTCPK
15.50
NaN%
Opening 09:30 02/13 EST
OPEN
--
PREV CLOSE
15.50
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
19.10
52 WEEK LOW
12.02
MARKET CAP
862.86M
P/E (TTM)
-157.5203
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at GNIIF last week (0908-0912)?
Weekly Report · 09/15/2025 12:13
Weekly Report: what happened at GNIIF last week (0901-0905)?
Weekly Report · 09/08/2025 12:16
Weekly Report: what happened at GNIIF last week (0825-0829)?
Weekly Report · 09/01/2025 12:08
Weekly Report: what happened at GNIIF last week (0818-0822)?
Weekly Report · 08/25/2025 12:25
Weekly Report: what happened at GNIIF last week (0811-0815)?
Weekly Report · 08/18/2025 12:13
Weekly Report: what happened at GNIIF last week (0804-0808)?
Weekly Report · 08/11/2025 12:24
Weekly Report: what happened at GNIIF last week (0728-0801)?
Weekly Report · 08/04/2025 12:27
Weekly Report: what happened at GNIIF last week (0721-0725)?
Weekly Report · 07/28/2025 12:28
More
About GNIIF
GNI Group Ltd is a Japan-based company engaged in pharmaceutical business and medical device business. The Company conducts global pharmaceutical research and development, manufacturing and distribution and biomaterials business. The Company operates in two business segments. The Pharmaceuticals segment conducts research and development, manufacturing, and sale of developed compounds, including ETUARY sold in the China market and Hydronidone (F351), which is in clinical trials. The main products also include other pharmaceuticals and reagents. The Medical Devices segment develops, manufactures, and sells medical devices such as biomaterials in the United States. This segment also includes medical device Designated Marketing Authorization Holder (DMAH) and In-Country Caretaker (ICC) services. The Company also conducts clinical and business development in the United States and conducts clinical development of F351 for Metabolic Dysfunction-Associated Steatohepatitis in the United States.

Webull offers GNI Group Ltd stock information, including OTCPK: GNIIF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GNIIF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GNIIF stock methods without spending real money on the virtual paper trading platform.